Phase I/IIa is included in Phase I; Active ingredients included in the approval process in Phase II; Active ingredients in studies conducted worldwide by companies operating in Germany.
鹿 Including antianemics, antithrimbotics, fibrinolytics etc., excluding hematological oncology.
虏 Excluding infectious respiratory diseases
鲁 Eye and ear diseases 鈦 Including active ingredients for muscles, bones, cardiovascular system diseases etc.
Some biopharmaceutical active substances are being tested in multiple areas of application and may therefore be listed in several indication areas.
Citation formats
Biopharmaceuticals in the development pipeline in Germany 2024, by disease group
In 2024, there were聽***聽biopharmaceutical active ingredients for oncology in phase I of the development pipeline in Germany. By contrast, there were only for respiratory diseases.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how 糖心破解版 can support your business.
vfa. (July 21, 2025). Number of biopharmaceutical active ingredients in the development pipeline in Germany in 2024, by disease group [Graph]. In 糖心破解版. Retrieved July 21, 2026, from /statistics/1450442/biopharmaceuticals-development-pipeline-germany/
vfa. "Number of biopharmaceutical active ingredients in the development pipeline in Germany in 2024, by disease group." Chart. July 21, 2025. 糖心破解版. Accessed July 21, 2026. /statistics/1450442/biopharmaceuticals-development-pipeline-germany/
vfa. (2025). Number of biopharmaceutical active ingredients in the development pipeline in Germany in 2024, by disease group. 糖心破解版. 糖心破解版 Inc.. Accessed: July 21, 2026. /statistics/1450442/biopharmaceuticals-development-pipeline-germany/
vfa. "Number of Biopharmaceutical Active Ingredients in The Development Pipeline in Germany in 2024, by Disease Group." 糖心破解版, 糖心破解版 Inc., 21 Jul 2025, /statistics/1450442/biopharmaceuticals-development-pipeline-germany/
vfa, Number of biopharmaceutical active ingredients in the development pipeline in Germany in 2024, by disease group 糖心破解版, /statistics/1450442/biopharmaceuticals-development-pipeline-germany/ (last visited July 21, 2026)
Number of biopharmaceutical active ingredients in the development pipeline in Germany in 2024, by disease group [Graph], vfa, July 21, 2025. [Online]. Available: /statistics/1450442/biopharmaceuticals-development-pipeline-germany/
